Lamivir HBV Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Hepatitis B. Secondary and off-label uses of Lamivir HBV Tablet have also been mentioned below.
The correct dosage of Lamivir HBV Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Lamivir HBV Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Lamivir HBV Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Lamivir HBV Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Lamivir HBV Tablet's effects on the liver, heart and kidney are discussed below in the Lamivir HBV Tablet related warnings section.
Lamivir HBV Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Lamivir HBV Tablet in conditions like Kidney Disease, Pancreatitis. Some other conditions that can be affected by Lamivir HBV Tablet are listed in the contraindications section below.
Besides this, Lamivir HBV Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Lamivir HBV Tablet is considered safe while driving, and is addictive.
Lamivir HBV Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Lamivir HBV Tablet safe for pregnant women?
Lamivir can have harmful effects in pregnant women. If you experience any discomfort after using Lamivir, then discontinue the use and take your doctor's advice.
Is the use of Lamivir HBV Tablet safe during breastfeeding?
Lamivir may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Lamivir, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Lamivir.
What is the effect of Lamivir HBV Tablet on the Kidneys?
Lamivir may have mild side effects on the kidneys.
What is the effect of Lamivir HBV Tablet on the Liver?
Lamivir is rarely harmful for the liver.
What is the effect of Lamivir HBV Tablet on the Heart?
There are no any side effects of Lamivir for the heart.
Lamivir HBV Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lamivir HBV Tablet unless your doctor advises you to do so -
Is this Lamivir HBV Tablet habit forming or addictive?
Lamivir HBV Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Lamivir HBV Tablet since it does not cause drowsiness.
Is it safe?
Yes, Lamivir HBV Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Lamivir HBV Tablet for mental disorders.
Interaction between Food and Lamivir HBV Tablet
Taking Lamivir HBV Tablet with food does not harm your health.
Interaction between Alcohol and Lamivir HBV Tablet
Consult your doctor before consuming alcohol while taking Lamivir HBV Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99